We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02535338
Brief Title: Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer

First Submitted : August 27, 2015
First Submitted that Met QC Criteria : August 27, 2015
First Posted : August 28, 2015 (Estimate)

Results First Submitted : April 11, 2022
Results First Submitted that Met QC Criteria : May 31, 2022
Results First Posted : June 22, 2022

Last Update Submitted that Met QC Criteria : September 20, 2022
Last Update Posted : October 12, 2022